TCF7L2 Gene and Weight Loss in Diabetes Prevention
Author Information
Author(s): Jeanne M. McCaffery, Kathleen A. Jablonski, Paul W. Franks, Sam Dagogo-Jack, Rena R. Wing, William C. Knowler, Linda Delahanty, Dana Dabelea, Richard Hamman, Alan R. Shuldiner, Jose C. Florez
Primary Institution: The Biostatistics Center, The George Washington University
Hypothesis
Does the TCF7L2 rs7903146 variant predict resistance to weight loss and affect proinsulin processing in high-risk individuals?
Conclusion
The TCF7L2 genotypes do not affect weight loss ability, but they do influence the proinsulin to insulin ratio over time.
Supporting Evidence
- The T allele at rs7903146 was associated with higher fasting proinsulin at baseline.
- No significant differences in weight loss were observed by genotype at rs7903146.
- The proinsulin to insulin ratio increased over 2.5 years for T allele carriers.
Takeaway
People with a certain gene variant can lose weight to reduce diabetes risk, but they still have problems with insulin production.
Methodology
The study analyzed data from a randomized controlled trial with 2,994 participants over 2.5 years, focusing on the TCF7L2 rs7903146 variant's effects on weight loss and proinsulin processing.
Potential Biases
Potential biases related to self-reported ethnicity and treatment adherence.
Limitations
The study may not generalize to all populations as it focused on high-risk individuals in a specific trial.
Participant Demographics
Participants were primarily high-risk adults with a BMI of 24 or higher, including various ethnicities such as Caucasian, African American, Hispanic, and Asian.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website